Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene, ENSG00000232409, is a **pseudogene** in the human genome annotated as *pseudogene similar to part of WD repeat domain 55 (WDR55)*. It is labeled as AC019185.2 in some databases[3]. Pseudogenes are typically non-functional DNA sequences related to known genes but do not encode functional proteins. Unlike the parent gene WDR55, which encodes a nucleolar protein involved in rRNA processing and organogenesis[5][8], this pseudogene does not appear to have protein-coding potential, therapeutic relevance, or disease associations[2][3]. The parent gene, WDR55, is a member of the WD40 repeat protein family, important for protein–protein interactions, but this pseudogene lacks evidence for similar biological activities or clinical significance in humans[5][7][8]. Summary: ENSG00000232409 is a pseudogene, **not a functional molecular target**, with no drug, biomarker, or disease relevance to date[2][3]. The entry is only appropriate for use as a reference to gene annotation rather than as a target for therapeutic or biomarker research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of WD repeat domain 55.